Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY: EW )

68.52 +0.39 (+0.57%)
Official Closing Price Updated: 4:10 PM EDT, Sep 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Edwards Lifesciences

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Nasdaq, S&P Futures Slide On More Negative Tech Tidings As Focus Shifts To Q2 GDP Data: Strategist Says Trump Trades May Not Work Even If Ex-President Retakes White House
Sentiment continues to be jittery, with the major index futures priming for a lower opening on Thursday as traders look ahead to the first read of second-quarter GDP data and more earnings. The tech... 
Via Benzinga
Topics Government Stocks
Exposures Political US Equities
Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
P/E Ratio Insights for Edwards Lifesciences
Via Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $33,000 Today
Via Benzinga
The Analyst Landscape: 13 Takes On Edwards Lifesciences
Via Benzinga
EW Stock Earnings: Edwards Lifesciences Beats EPS, Misses Revenue for Q2 2024
EW stock results show that Edwards Lifesciences beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Edwards Stock Plummets After Medtech Slashes Its TAVR Outlook For The Year
The company now expects full-year sales in its TAVR division to climb 5% to 7%. 
Via Investor's Business Daily
US Stocks Tumble, Magnificent 7 Wipe Out $570 Billion As Mega-Tech Earnings Disappoint, VIX Spikes: What's Driving Markets Wednesday?
Wall Street experienced a turbulent session on Wednesday, with the S&P 500 index heading toward its worst performance in over a year and the tech-focused Nasdaq 100 eyeing its fifth decline in the last... 
Via Benzinga
Topics Stocks
Exposures US Equities
Peering Into Edwards Lifesciences's Recent Short Interest
Via Benzinga
$100 Invested In Edwards Lifesciences 20 Years Ago Would Be Worth This Much Today
Via Benzinga
If You Invested $100 In This Stock 20 Years Ago, You Would Have $2,900 Today
Via Benzinga
US Stocks Could Open Sharply Lower As Tesla, Alphabet Earnings Offer No Cheer: Analyst Says This Bodes Well For Small-Caps, 'Only Takes A Small Spark To Ignite A Powerful Move'
Wall Street is gearing up for a negative start on Thursday, as traders mull over earnings from Tesla, Inc. (NASDAQ:TSLA) and Alphabet, Inc. 
Via Benzinga
UnitedHealth, Edwards Lifesciences, First Citizens Bank And More: CNBC's 'Final Trades'
UnitedHealth Group was declared a "solid" healthcare company on CNBC. Cantor Fitzgerald analyst Sarah James maintains a price target of $591. 
Via Benzinga
Stock Market Revs To Highs On Nvidia, CrowdStrike, Yields: Weekly Review
The Nasdaq and S&P 500 hit record highs, but small caps retreated. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
What Analysts Are Saying About Edwards Lifesciences Stock
Via Benzinga
Looking Into Edwards Lifesciences's Recent Short Interest
Via Benzinga
Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally
The earnings parade continues this week with a slightly accelerated tempo as analysts brace for a healthy reporting season. 
Via Benzinga
Assessing Edwards Lifesciences: Insights From 11 Financial Analysts
Via Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $16,000 Today
Via Benzinga
BD Bolsters Portfolio With $4.2B Cash Deal For Edwards Lifesciences' Critical Care Group: Details
BD (Becton, Dickinson and Company) will acquire Edwards Lifesciences' Critical Care product group for $4.2 billion in cash. This acquisition enhances BD's portfolio with advanced AI-enabled monitoring... 
Via Benzinga
Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal
Edwards Lifesciences stock rallied Monday on medtech giant Becton Dickinson's plan to buy a key division for $4.2 billion. 
Via Investor's Business Daily
Here's How Much $1000 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth Today
Via Benzinga
Indian Rival Meril Accuses Edwards Lifesciences Of Anti-Competitive Behavior In EU Antitrust Complaint
Edwards Lifesciences faces EU antitrust complaint from Meril over patent disputes, intensifying regulatory scrutiny. Recent actions aim to ensure fair competition, affordability, as Meril alleges... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Is It Time To Get Defensive With Healthcare Stocks?
Based in Irvine, California, Edwards Lifesciences is a prominent American medical technology firm. 
Via Talk Markets
Decoding Edwards Lifesciences's Options Activity: What's the Big Picture?
Via Benzinga
Behind the Scenes of Edwards Lifesciences's Latest Options Trends
Via Benzinga
Jim Cramer: These Airline Stocks 'Trade Wildly,' Edwards Lifesciences 'At The Right Level To Buy'
Cramer likes Delta Air Lines, United Airlines Holdings. "Now, remember, they're very inexpensive stocks, but they trade wildly. But I do like Delta," he added. 
Via Benzinga
Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review
Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser. 
Via Investor's Business Daily
EW Stock Earnings: Edwards Lifesciences Beats EPS, Beats Revenue for Q1 2024
EW stock results show that Edwards Lifesciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Edwards Lifesciences Nabs Quarterly Beat And Plans A 'Critical' Spinoff
The company also raised its outlook for the year and now expects 8% to 10% sales growth. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.